<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02598232</url>
  </required_header>
  <id_info>
    <org_study_id>LU-DL-14-001</org_study_id>
    <nct_id>NCT02598232</nct_id>
  </id_info>
  <brief_title>The Efficacy and Safety of the 1,414 nm Nd:YAG Laser System for Alleviating Back Pain in a Lumbar Disc Patient</brief_title>
  <official_title>A 24-week, Single-center, Open-label, Clinical Study to Evaluate the Efficacy and Safety of the 1,414nm Nd:YAG Laser System Added to PEN to Further Alleviate Back Pain in a Lumbar Herniated Intervertebral Disc Patient</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>LUTRONIC Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>LUTRONIC Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate the efficacy and safety of the 1,414nm Nd:YAG laser system&#xD;
      (ACCUPLASTI) added to Percutaneous Epidural Neuroplasty (PEN), a conventional treatment, to&#xD;
      alleviate back pain in a lumbar herniated intervertebral disc patient.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the Oswestry Disability Index</measure>
    <time_frame>Day 0, 24 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in the Oswestry Disability Index</measure>
    <time_frame>Day 0, 4 weeks, 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Visual Analogue Scale</measure>
    <time_frame>Day 0, 4 weeks, 12 weeks, 24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>12-Item Short-form Health Survey</measure>
    <time_frame>Day 0, 4 weeks, 12 weeks, 24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the pain level in 4 steps of excellent, good, fair, poor, according to MacNab's Criteria</measure>
    <time_frame>Day 0, 4 weeks, 12 weeks, 24 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Lumbar Herniated Intervertebral Disc</condition>
  <arm_group>
    <arm_group_label>1,414nm Nd:YAG laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>It has high absorption coefficient in water and a short pulse width.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>1,414nm Nd:YAG Laser System</intervention_name>
    <description>It has high absorption coefficient in water and a short pulse width.</description>
    <arm_group_label>1,414nm Nd:YAG laser</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients 19-79 years old&#xD;
&#xD;
          -  Patients with moderate disability based on the Oswestry Disability Index (ODI), among&#xD;
             those diagnosed with a single level of unilateral herniated intervertebral disc among&#xD;
             the 3rd-4th and 4th-5th lumbar vertebrae, or the 5th lumbar vertebra-sacral vertebra&#xD;
             with back pain or radiating pain in the lower extremities that has been unresponsive&#xD;
             to conservative therapy for more than six weeks&#xD;
&#xD;
          -  Patients who have language skills enough to answer questionnaires&#xD;
&#xD;
          -  Patients who agree to voluntarily participate in this study and to sign the Informed&#xD;
             Consent Form, and who are able to participate for the entire period of this study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with a multi-level, far-lateral, or bilateral lumbar herniated intervertebral&#xD;
             disc&#xD;
&#xD;
          -  Patients who use an electronic medical device for their cardiovascular system&#xD;
&#xD;
          -  Patients who have spondylolisthesis in the relevant lesion&#xD;
&#xD;
          -  Patients with neurological defects&#xD;
&#xD;
          -  Patients who had undergone surgery on the relevant lumbar vertebra&#xD;
&#xD;
          -  Patients with cauda equina syndrome&#xD;
&#xD;
          -  Patients with congenital spinal deformity&#xD;
&#xD;
          -  Patients with spinal fracture&#xD;
&#xD;
          -  Patients with spinal infection, tumor, or other form of inflammatory spondylopathy&#xD;
&#xD;
          -  Patients with coagulation disorder&#xD;
&#xD;
          -  Patients with a history of malignant tumor (except those with a cured tumor and no re-&#xD;
             occurrence for the last five years)&#xD;
&#xD;
          -  Patients who had participated in another clinical study within 30 days from their&#xD;
             screening visit&#xD;
&#xD;
          -  Female patients with child-bearing potential who do not agree to use a medically&#xD;
             acceptable contraceptive method* for up to 24 weeks after the use of the&#xD;
             investigational medical device during this study&#xD;
&#xD;
               -  Medically acceptable contraceptive method: Condom, oral contraceptive pills taken&#xD;
                  continuously for more than three months, contraceptive injection or implants,&#xD;
                  intra- uterine contraceptive device, etc.&#xD;
&#xD;
          -  Patients who are pregnant or breastfeeding&#xD;
&#xD;
          -  Other patients who are considered unfit to participate in this study with clinically&#xD;
             significant findings based on the investigator's judgment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Keung-nyun Kim, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Severance Hospital</affiliation>
  </overall_official>
  <verification_date>April 2016</verification_date>
  <study_first_submitted>November 4, 2015</study_first_submitted>
  <study_first_submitted_qc>November 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 5, 2015</study_first_posted>
  <last_update_submitted>March 7, 2017</last_update_submitted>
  <last_update_submitted_qc>March 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

